Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?
Al-Dewik, Nader I., Morsi, Hisham M., Samara, Muthanna M., Ghasoub, Rola S., Gnanam, Cinquea C., Bhaskaran, Subi K., Nashwan, Abdulqadir J., Al-Jurf, Rana M., Ismail, Mohamed A., Alsharshani, Mohammed M., Alsayab, Ali A., Ben-Omran, Tawfeg I., Khatib, Rani B., Yassin, Mohamed A.
Published in Clinical Medicine Insights. Oncology (01.01.2016)
Published in Clinical Medicine Insights. Oncology (01.01.2016)
Get full text
Journal Article
Book Review
Is Adherence to Imatinib Mesylate Treatment among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?
Nader I. Al-Dewik, Hisham M. Morsi, Muthanna M. Samara, Rola S. Ghasoub, Cinquea C. Gnanam, Subi K. Bhaskaran, Abdulqadir J. Nashwan, Rana M. Al-Jurf, Mohamed A. Ismail, Mohammed M. Alsharshani, Ali A. Alsayab, Tawfeg I. Ben-Omran, Rani B. Khatib, Mohamed A. Yassin
Published in Clinical Medicine Insights. Oncology (01.01.2016)
Published in Clinical Medicine Insights. Oncology (01.01.2016)
Get full text
Journal Article